Oral Communications 2 (Brief Communications)
1Institute of Health and Society, University of Newcastle upon Tyne, Newcastle upon Tyne, UK; 2Department of Clinical Biochemistry, University Hospital of North Durham, Durham, Durham, UK; 3Department of Paediatric Endocrinology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK; 4Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle Upon Tyne, UK; 5Institute of Human Genetics, Newcastle University, Institute of Human Genetics, Newcastle University, Centre for Life, Central Parkway, Newcastle-upon-Tyne, UK.
Kirby G A
Morgan N V
Forman J R
Barrett T G
Maher E R
1University of Birmingham, Birmingham, UK; 2Uludag University, Bursa, Turkey; 3Institut Pasteur, Paris, France; 4Dr Sami Ulus Woman Health, Children Research Hospital, Ankara, Turkey; 5Dokuz Eylül University, Izmir, Turkey; 6Yuzuncu Yil University, Van, Turkey; 7Birmingham Childrens Hospital, Birmingham, UK.
Alatzoglou K S
Dattani M T
1Developmental Endocrinology Research Group, UCL Institute of Child Health, London, UK; 2Clinical and Molecular Genetics Unit, UCL Institute of Child Health, London, UK; 3Neural Development Unit, UCL Institute of Child Health, London, UK; 4Department of Childs Health, Sheffield Childrens Hospital, Sheffield, UK; 5Department of Paediatric Endocrinology, University of Pavia, Pavia, Italy.
Balan K K
Cheetham T D
Acerini C L
1Weston Centre, Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, UK; 2Department of Nuclear Medicine, Addenbrookes Hospital, Cambridge, UK; 3Department of Paediatrics, Royal Victoria Infirmary, Newcastle upon Tyne, UK.